Home › Overweight › California › Simi Valley
Overweight clinical trials in Simi Valley, CA
4 studies for Overweight are looking for participants at sites in and around Simi Valley (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
RecruitingPhase 3
- Southern California Retina Specialists, West Hills · 9 mi away
- San Fernando Valley Health Institute, Canoga Park · 11 mi away
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- Southern California Retina Specialists, West Hills · 9 mi away
- San Fernando Valley Health Institute, Canoga Park · 11 mi away
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- San Fernando Valley Health Institute, Canoga Park · 11 mi away
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- San Fernando Valley Health Institute, Canoga Park · 11 mi away
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL29 studies
- Orlando, FL27 studies
- Dallas, TX23 studies
- Miami, FL23 studies
- Washington, DC20 studies
- Atlanta, GA20 studies
- Austin, TX19 studies
- Las Vegas, NV19 studies
- Jacksonville, FL19 studies
- New York City, NY19 studies
Other studies in Simi Valley
- Type 2 Diabetes8 studies
- Obesity5 studies
- Cardiovascular Disease4 studies
- Heart Failure4 studies
- Atrial Fibrillation4 studies
- Blood Clots4 studies
- Major Depressive Disorder3 studies
- Atopic Dermatitis (Eczema)3 studies
- High Blood Pressure3 studies
- Steatotic Liver Disease3 studies
- Metabolic Disorders3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.